drugset / Trial / NCT02012335

Ketamine Use in Electroconvulsive Therapy

NCT02012335 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether combination of ketamine plus electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects.

Timeline

Start
2014-01
Primary completion
2016-01
Completion
2016-01

Outcome

Outcome not reported

Stopped: “Methodologicals and logistics issues.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.05 mg/kg —